36897111000001103: Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\UK product\Virtual medicinal product\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\UK product\Virtual therapeutic moiety\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\UK product\Trade family\Stalevo\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing catechol-O-methyltransferase inhibitor\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 125mg/31.25mg/200mg tablets\Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

113157801000001110 Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

113157901000001116 Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Is a	Generic Stalevo 125mg/31.25mg/200mg tablets	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has active ingredient	Entacapone	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has specific active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has specific active ingredient	Entacapone	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has specific active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Is a	Stalevo	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.) 100 tablet	Has AMP	True	Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
113157801000001110	Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
113157901000001116	Stalevo 125mg/31.25mg/200mg tablets (Originalis B.V.)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module